Payment overview · 2025
General Payments
$14.64
1 reported records · 1 companies
Healthcare provider profile · identity verified
Stephen Lambert
Allopathic & Osteopathic Physicians|Family Medicine · SLIDELL, LA · NPI 1609317999
Verified facts
What the public records show
CMS Open Payments records show Stephen Lambert received $14.64 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 213 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $14.64 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.64 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $14.64 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $14.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
213 | 47 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
40 | 40 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 737 | 213 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 676 | 220 |
| Levothyroxine Sodium | Levothyroxine Sodium | 609 | 145 |
| Amlodipine Besylate | Amlodipine Besylate | 579 | 183 |
| Gabapentin | Gabapentin | 428 | 138 |
| Pantoprazole Sodium | Pantoprazole Sodium | 386 | 114 |
| Metformin Hcl Er | Metformin Hcl | 337 | 109 |
| Lisinopril | Lisinopril | 294 | 81 |
| Losartan Potassium | Losartan Potassium | 289 | 97 |
| Omeprazole | Omeprazole | 288 | 84 |
| Metoprolol Succinate | Metoprolol Succinate | 267 | 78 |
| Alendronate Sodium | Alendronate Sodium | 265 | 75 |
| Tizanidine Hcl | Tizanidine Hcl | 250 | 94 |
| Doxycycline Hyclate | Doxycycline Hyclate | 236 | 211 |
| Pravastatin Sodium | Pravastatin Sodium | 222 | 66 |
| Metformin Hcl | Metformin Hcl | 215 | 69 |
| Eliquis | Apixaban | 213 | 47 |
| Trazodone Hcl | Trazodone Hcl | 206 | 67 |
| Valsartan | Valsartan | 197 | 58 |
| Potassium Chloride | Potassium Chloride | 191 | 71 |
| Fluticasone Propionate | Fluticasone Propionate | 184 | 63 |
| Meloxicam | Meloxicam | 184 | 66 |
| Hydrochlorothiazide | Hydrochlorothiazide | 182 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 177 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 174 | 52 |
| Ozempic | Semaglutide | 174 | 46 |
| Allopurinol | Allopurinol | 173 | 48 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 171 | 153 |
| Spironolactone | Spironolactone | 171 | 59 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 168 | 45 |
| Buspirone Hcl | Buspirone Hcl | 159 | 44 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 159 | 139 |
| Furosemide | Furosemide | 157 | 53 |
| Montelukast Sodium | Montelukast Sodium | 156 | 49 |
| Sertraline Hcl | Sertraline Hcl | 153 | 50 |
| Glimepiride | Glimepiride | 152 | 41 |
| Jardiance | Empagliflozin | 145 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 140 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 137 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 41 |
| Famotidine | Famotidine | 127 | 40 |
| Desloratadine | Desloratadine | 125 | 104 |
| Ezetimibe | Ezetimibe | 123 | 43 |
| Bupropion Xl | Bupropion Hcl | 117 | 35 |
| Mounjaro | Tirzepatide | 109 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 106 | 101 |
| Methylprednisolone | Methylprednisolone | 105 | 102 |
| Clopidogrel | Clopidogrel Bisulfate | 101 | 35 |
| Carvedilol | Carvedilol | 98 | 29 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 96 | 60 |
| Mupirocin | Mupirocin | 95 | 49 |
| Simvastatin | Simvastatin | 93 | 29 |
| Celecoxib | Celecoxib | 92 | 23 |
| Chlorthalidone | Chlorthalidone | 92 | 27 |
| Fluconazole | Fluconazole | 91 | 70 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 85 | 27 |
| Pregabalin | Pregabalin | 85 | 29 |
| Azelastine Hcl | Azelastine Hcl | 81 | 47 |
| Mirtazapine | Mirtazapine | 81 | 23 |
| Benazepril Hcl | Benazepril Hcl | 77 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 75 | 29 |
| Irbesartan | Irbesartan | 75 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 71 | 25 |
| Fenofibrate | Fenofibrate | 66 | 18 |
| Torsemide | Torsemide | 64 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 61 | 21 |
| Lovastatin | Lovastatin | 60 | 17 |
| Baclofen | Baclofen | 57 | 16 |
| Finasteride | Finasteride | 57 | 16 |
| Methocarbamol | Methocarbamol | 57 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 17 |
| Nortriptyline Hcl | Nortriptyline Hcl | 54 | 20 |
| Telmisartan | Telmisartan | 54 | 15 |
| Warfarin Sodium | Warfarin Sodium | 53 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 14 |
| Naproxen | Naproxen | 51 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 51 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 50 | 13 |
| Ketoconazole | Ketoconazole | 49 | 32 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 49 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 47 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 14 |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 27 |
| Synthroid | Levothyroxine Sodium | 42 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 42 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | 14 |
| Trulicity | Dulaglutide | 41 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 41 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 40 | 16 |
| Labetalol Hcl | Labetalol Hcl | 40 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 40 | 40 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 40 | 12 |
| Alprazolam | Alprazolam | 39 | 12 |
| Azithromycin | Azithromycin | 39 | 37 |
| Hydralazine Hcl | Hydralazine Hcl | 39 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 39 | suppressed |
| Cefdinir | Cefdinir | 38 | 37 |
| Clonidine Hcl | Clonidine Hcl | 38 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | 19 |
| Repatha Sureclick | Evolocumab | 38 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 37 | 11 |
| Atenolol | Atenolol | 37 | 11 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Tradjenta | Linagliptin | 37 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 34 |
| Metronidazole | Metronidazole | 36 | 33 |
| Wegovy | Semaglutide | 36 | suppressed |
| Linzess | Linaclotide | 35 | 21 |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | 12 |
| Topiramate | Topiramate | 33 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 33 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 32 | 21 |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 32 | 11 |
| Lagevrio (Eua) | Molnupiravir | 32 | 32 |
| Colchicine | Colchicine | 31 | 13 |
| Ondansetron Odt | Ondansetron | 31 | 18 |
| Prednisone | Prednisone | 31 | 19 |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Creon | Lipase/Protease/Amylase | 28 | 12 |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 18 |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Clonidine | Clonidine | 26 | suppressed |
| Folic Acid | Folic Acid | 26 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Lidocaine | Lidocaine | 25 | 15 |
| Tramadol Hcl | Tramadol Hcl | 25 | 12 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 24 | 22 |
| Lactulose | Lactulose | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 20 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 20 | 20 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Nexletol | Bempedoic Acid | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | 11 |
| Repatha Pushtronex | Evolocumab | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 17 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Nystatin | Nystatin | 17 | 11 |
| Terbinafine Hcl | Terbinafine Hcl | 17 | 12 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Nabumetone | Nabumetone | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Eplerenone | Eplerenone | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Phenazopyridine Hcl | Phenazopyridine Hcl | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Amlodipine-Valsartan-Hctz | Amlodipine/Valsartan/Hcthiazid | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.64 · 1 records | PFIZER INC. | NURTEC ODT, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error